Furthermore, in the case of COVID-19, the production of counterbalancing anti-inflammatory cytokines, specifically IL-10, may not function to limit the cytokine storm as previously thought, but rather enhance the pro-inflammatory environment in which a cytokine storm can develop. The gene discussed is IL10; the disease is COVID-19.